T0	Outcomes 1196 1205	P=0.002).
T1	Outcomes 1206 1232	CAF-specific pSMAD2 levels
T2	Outcomes 1284 1331	Experimentally, TGF-Î² signalling in fibroblasts
T3	Outcomes 1660 1720	increased cell growth, proliferation and clonogenic survival
T4	Outcomes 1787 1824	MCF7 and tumour weight and proportion